Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3462028rdf:typepubmed:Citationlld:pubmed
pubmed-article:3462028lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C0006674lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C0012472lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C1551359lld:lifeskim
pubmed-article:3462028lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:3462028pubmed:issue1lld:pubmed
pubmed-article:3462028pubmed:dateCreated1986-10-9lld:pubmed
pubmed-article:3462028pubmed:abstractTextPartial removal of monocytes from human peripheral blood mononuclear cells, or the addition of indomethacin, reduced the antiproliferative effect of 1,25(OH)2D3 on mitogen-stimulated mononuclear cells. Addition of 1,25(OH)2D3 (1 nM) to mitogen-stimulated mononuclear cells caused a 2-4-fold increase in prostaglandin E2 production during the second day of culture. The inhibitory effect of 1,25(OH)2D3 on lymphocyte proliferation is greatly augmented up to 7-fold in the presence of prostaglandin E2. We conclude that monocytes are involved in the inhibitory effect of 1,25(OH)2D3 on the mitogenic stimulation of human lymphocytes and that their action is probably mediated by prostaglandins.lld:pubmed
pubmed-article:3462028pubmed:languageenglld:pubmed
pubmed-article:3462028pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3462028pubmed:citationSubsetIMlld:pubmed
pubmed-article:3462028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3462028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3462028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3462028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3462028pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3462028pubmed:statusMEDLINElld:pubmed
pubmed-article:3462028pubmed:monthSeplld:pubmed
pubmed-article:3462028pubmed:issn0014-5793lld:pubmed
pubmed-article:3462028pubmed:authorpubmed-author:KorenRRlld:pubmed
pubmed-article:3462028pubmed:authorpubmed-author:NovogrodskyAAlld:pubmed
pubmed-article:3462028pubmed:authorpubmed-author:RavidAAlld:pubmed
pubmed-article:3462028pubmed:authorpubmed-author:ShohamiEElld:pubmed
pubmed-article:3462028pubmed:authorpubmed-author:LibermanU AUAlld:pubmed
pubmed-article:3462028pubmed:authorpubmed-author:RotemCClld:pubmed
pubmed-article:3462028pubmed:issnTypePrintlld:pubmed
pubmed-article:3462028pubmed:day1lld:pubmed
pubmed-article:3462028pubmed:volume205lld:pubmed
pubmed-article:3462028pubmed:ownerNLMlld:pubmed
pubmed-article:3462028pubmed:authorsCompleteYlld:pubmed
pubmed-article:3462028pubmed:pagination113-6lld:pubmed
pubmed-article:3462028pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:meshHeadingpubmed-meshheading:3462028-...lld:pubmed
pubmed-article:3462028pubmed:year1986lld:pubmed
pubmed-article:3462028pubmed:articleTitle1,25-Dihydroxyvitamin D3 enhances prostaglandin E2 production by monocytes. A mechanism which partially accounts for the antiproliferative effect of 1,25(OH)2D3 on lymphocytes.lld:pubmed
pubmed-article:3462028pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3462028pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:3462028pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3462028lld:pubmed